mwalker wrote:Chemo, modified FOLFOX (no Oxaliplatin, no Avastin, no Irinotecan) will begin Monday. (Other chemo drugs will be added as needed after the PET and once a path has been established, there is a focus on QoL
no oxi-, no iri-, no Avastin .... all that is left is basic 5FU - LV with aa loose promise of something as needed.
A lot of approved CRC 3rd-4th line drugs are low performers with side effects. hmmmm
Well, we shrunk, broke up and/or dissolved several 2-3 cm unbiopsied lesions in the liver in the chemo - chemistry iterations after 2nd surgery (months 13-24), perhaps both a surgical benefit with fewer stem cells and cancer enhancing cytokines, and our improving ++ to +++ chemistry, with some very notable nice chemical assault factors.
We may also have damaged these liver lesions in the initial assault the year before 1st surgery, right after diagnosis when our initial (neoadjuvant) immune package apparently generated a huge immune attack, making mush out of a lot of suspicious tissues. The surgeon initially classed my wife as an R2 resection - large leftover residue except they were already necrosed at 4 weeks by a massive granulocytic attack (unusual and weird to drs).
In year 2, our consulting radiologist was impressed about the liver actions, because he marveled about it several times.
1/26 mwalker wrote: I’ve got an s-ton of blood test results; give me a couple of days to collate them.
now or yesterday is the time